Genedrive steps up a gear in USA with first shipments

The share price of Genedrive (AIM: GDR) rose by 20 percent at the opening of the markets following announcement that it is making tangible moves in the USA.

Near patient molecular diagnostics company genedrive revealed that the first shipments to the USA of its Genedrive 96 SARS-CoV-2 Kits has started.

These shipments follow a previous announcement regarding its distribution agreement with Beckman Coulter Life Science. Alongside the shipping of the kits to the USA, GDR has also completed commercial and technical training with sales representatives at Beckman Coulter.

Beckman Coulter can now start preparing to sell and roll-out the supplied kits to the wider market.

Commenting on the shipments was CEO David Budd:

“This is an important milestone for genedrive as the first shipments of our Genedrive 96 SAR-CoV-2 kit are exported to the US. We are very optimistic about the US market for Covid PCR testing and it has market drivers that are favorable to the adoption of the genedrive assay: efficiency, ease of use, automation friendly, and scalability.”

The share price of GDR is currently trading at 152p.

Let's Talk

Getting into CBD stocksThanks I'm going to wait for MXC to dip a bit more big overra … Read More
Argo Blockchain Share Price Predi …Update. I'm not into even more profit. Am holding unless Bitc … Read More
ODX target price is?People obviously wanted to see we have a £200m contract in the bag … Read More
Remote Monitored Systems shares - …Hahahaha. The RMS patrol are still out and about - just sell out o … Read More
What shares is everyone buying no …Cine I know it's a risky but its got a lot of volume. BP on t … Read More
Hey, profit awaits! Free Sharebuyers Newsletter

Receive hot tips you can profit from - only sent when it matters. Twitter: @ShareBuyers.